viral vector vaccine (AstraZeneca ltd)
90
Structured Review
AstraZeneca ltd
viral vector vaccine
Viral Vector Vaccine, supplied by AstraZeneca ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/viral+vector+vaccine/viral+vector+vaccines/pm39879847-3-1-1
Average 90 stars, based on 1 article reviews
Viral Vector Vaccine, supplied by AstraZeneca ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/viral+vector+vaccine/viral+vector+vaccines/pm39879847-3-1-1
Average 90 stars, based on 1 article reviews
viral vector vaccine - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Infection:Article Title: How well do different COVID-19 vaccines protect against different viral variants? A systematic review and meta-analysis. Article Snippet: The AstraZeneca Viral Vector Vaccine and the Johnson & Johnson Viral Vector Vaccine also demonstrated protection against the Alpha variant, with RR values of 0.29 (95% CI 0.22 to 0.38) and 0.25 (95% CI 0.15 to 0.42), respectively (Figure 4 B). .. While the Pfizer-BioNTech Nucleic Acid Vaccine, Clover Biopharmaceuticals Protein Subunit Vaccine, Johnson & Johnson Article Title: How well do different COVID-19 vaccines protect against different viral variants? A systematic review and meta-analysis Article Snippet: The AstraZeneca Viral Vector Vaccine and the Johnson & Johnson Viral Vector Vaccine also demonstrated protection against the Alpha variant, with RR values of 0.29 (95% CI 0.22 to 0.38) and 0.25 (95% CI 0.15 to 0.42), respectively (Figure ). .. While the Pfizer-BioNTech Nucleic Acid Vaccine, Clover Biopharmaceuticals Protein Subunit Vaccine, Johnson & Johnson Variant Assay:Article Title: How well do different COVID-19 vaccines protect against different viral variants? A systematic review and meta-analysis. Article Snippet: Protec tive effec ts of the Johnson & Johnson Viral Vector Vaccine declined with the emergence of subsequent variants, with the lowest RR observed for wild-type (RR = 0.27, 95% CI 0.21 to 0.34) and the Alpha variant (RR = 0.27, 95% CI: 0.15 to 0.49) ( Supplement 5A). .. The Article Title: How well do different COVID-19 vaccines protect against different viral variants? A systematic review and meta-analysis Article Snippet: Both the Moderna COVID-19 Vaccine and Pfizer-BioNTech Nucleic Acid Vaccine demonstrated the highest protection against wild-type variants, showing similar RR values (RR=0.07; 95% CI 0.06 to 0.09 and RR=0.08; 95% CI 0.05 to 0.12, respectively). .. Sputnik V showed the second highest protective effects against the wild-type variant, with a RR of 0.08 (95% CI 0.05 to 0.15), followed by Article Title: How well do different COVID-19 vaccines protect against different viral variants? A systematic review and meta-analysis Article Snippet: Protective effects of the Johnson & Johnson Viral Vector Vaccine declined with the emergence of subsequent variants, with the lowest RR observed for wild-type (RR=0.27, 95% CI 0.21 to 0.34) and the Alpha variant (RR=0.27, 95% CI: 0.15 to 0.49) ( ). .. The Article Title: How well do different COVID-19 vaccines protect against different viral variants? A systematic review and meta-analysis Article Snippet: The AstraZeneca Viral Vector Vaccine and the Johnson & Johnson Viral Vector Vaccine also demonstrated protection against the Alpha variant, with RR values of 0.29 (95% CI 0.22 to 0.38) and 0.25 (95% CI 0.15 to 0.42), respectively (Figure ). .. While the Pfizer-BioNTech Nucleic Acid Vaccine, Clover Biopharmaceuticals Protein Subunit Vaccine, Johnson & Johnson Article Title: How well do different COVID-19 vaccines protect against different viral variants? A systematic review and meta-analysis Article Snippet: For example, the Johnson & Johnson Viral Vector Vaccine exhibited a high protective effect against the wild-type and the Alpha variant, but its protection decreased notably against Delta and other variants. .. A similar pattern was observed for the Plasmid Preparation:Article Title: Safety comparison between Pfizer BNT162b2, Moderna mRNA-1273, and AstraZeneca AZD1222 in a Nationwide prospective cohort survey at the beginning of the severe acute respiratory syndrome coronavirus 2 vaccination in Japan. Article Snippet: The Pfizer and Moderna mRNA vaccines were associated with a higher frequency of fever after the second dose than after the first dose. .. The Article Title: How well do different COVID-19 vaccines protect against different viral variants? A systematic review and meta-analysis Article Snippet: For example, the Johnson & Johnson Viral Vector Vaccine exhibited a high protective effect against the wild-type and the Alpha variant, but its protection decreased notably against Delta and other variants. .. A similar pattern was observed for the Article Title: Vaccines Efficacy against Delta and Omicron Variants: A Comparative Study of Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV-2) Vaccines Article Snippet: .. Initial effectiveness after two (2) doses was similar to Omicron for mRNA vaccines (Pfizer-BioNTech and Moderna) and Vaccines:Article Title: Vaccines Efficacy against Delta and Omicron Variants: A Comparative Study of Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV-2) Vaccines Article Snippet: .. Initial effectiveness after two (2) doses was similar to Omicron for mRNA vaccines (Pfizer-BioNTech and Moderna) and |